Published in Lancet on March 24, 2001
Actinic Cheilitis Pre-Treated With DNA Repair Enzyme Cream | NCT03224715
Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer (2008) 4.34
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst (2010) 2.80
Shining a light on xeroderma pigmentosum. J Invest Dermatol (2012) 2.33
Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J Invest Dermatol (2008) 1.29
Liposomes as nanomedical devices. Int J Nanomedicine (2015) 1.29
Green tea polyphenols prevent UV-induced immunosuppression by rapid repair of DNA damage and enhancement of nucleotide excision repair genes. Cancer Prev Res (Phila) (2010) 1.29
Nucleotide excision repair and cancer. J Mol Histol (2006) 1.27
Polyphenols: skin photoprotection and inhibition of photocarcinogenesis. Mini Rev Med Chem (2011) 1.08
Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. Proc Natl Acad Sci U S A (2004) 1.04
New careers for antioxidants. Proc Natl Acad Sci U S A (2002) 0.95
Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells. J Immunol (2011) 0.93
Photosensitivity, corneal scarring and developmental delay: Xeroderma Pigmentosum in a tropical country. Cases J (2008) 0.90
Nonsurgical innovations in the treatment of nonmelanoma skin cancer. J Clin Aesthet Dermatol (2010) 0.89
Molecular cancer prevention: Current status and future directions. CA Cancer J Clin (2015) 0.86
Targeting ornithine decarboxylase for the prevention of nonmelanoma skin cancer in humans. Cancer Prev Res (Phila) (2010) 0.85
Ageing, science and the cosmetics industry. The micro-inflammatory model serves as a basis for developing effective anti-ageing products for the skin. EMBO Rep (2005) 0.83
Green tea prevents non-melanoma skin cancer by enhancing DNA repair. Arch Biochem Biophys (2010) 0.82
Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging. Mech Ageing Dev (2008) 0.82
TAT-mediated delivery of a DNA repair enzyme to skin cells rapidly initiates repair of UV-induced DNA damage. J Invest Dermatol (2010) 0.82
Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice. Proc Natl Acad Sci U S A (2004) 0.80
Photoimmunology. Dermatol Clin (2014) 0.80
Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review. Biomed Res Int (2015) 0.79
The Skin Microbiome: Is It Affected by UV-induced Immune Suppression? Front Microbiol (2016) 0.78
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA. PLoS One (2015) 0.76
Preventive Long-Term Effects of a Topical Film-Forming Medical Device with Ultra-High UV Protection Filters and DNA Repair Enzyme in Xeroderma Pigmentosum: A Retrospective Study of Eight Cases. Case Rep Dermatol (2014) 0.76
Modulation of the processive abasic site lyase activity of a pyrimidine dimer glycosylase. DNA Repair (Amst) (2011) 0.76
Prospects for skin cancer treatment and prevention: the potential contribution of an engineered virus. J Invest Dermatol (2011) 0.76
Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders. J Invest Dermatol (2014) 0.76
New agents for prevention of ultraviolet-induced nonmelanoma skin cancer. Semin Cutan Med Surg (2011) 0.76
Dietary proanthocyanidins inhibit UV radiation-induced skin tumor development through functional activation of the immune system. Mol Nutr Food Res (2016) 0.76
Xeroderma pigmentosum: clinicopathological review of the multiple oculocutaneous malignancies and complications. Indian J Surg Oncol (2014) 0.75
Xeroderma Pigmentosum with Severe Neurological Manifestations/De Sanctis-Cacchione Syndrome and a Novel XPC Mutation. Case Rep Med (2017) 0.75
Poisson distribution to assess actinic keratoses in xeroderma pigmentosum. Lancet (2001) 0.75
Poisson distribution to assess actinic keratoses in xeroderma pigmentosum. Lancet (2001) 0.75
Living related hemi-face skin transplant using radial forearm free flap for a xeroderma pigmentosa patient: early outcome. Head Neck Oncol (2010) 0.75
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J Exp Med (1978) 9.51
Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest (2001) 5.94
The major histocompatibility complex of the mouse. Science (1979) 4.76
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Divergence time and population size in the lineage leading to modern humans. Theor Popul Biol (1995) 4.31
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med (1972) 3.96
The H-2 model for the major histocompatibility systems. Transplant Rev (1971) 3.82
List of congenic lines of mice. I. Lines with differences at alloantigen loci. Transplantation (1973) 3.73
Bracteomania, an inflorescence anomaly, is caused by the loss of function of the MADS-box gene squamosa in Antirrhinum majus. EMBO J (1992) 3.60
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Serological identification of an Ir-region product. Science (1973) 3.32
The traditional and a new version of the mouse H-2 complex. Nature (1981) 3.12
The nature and significance of platelet products in human plasma. Br J Haematol (1967) 2.84
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
MHC polymorphism pre-dating speciation. Nature (1988) 2.70
Therapy for acute otitis media. Preference of parents for oral or parenteral antibiotic. Arch Pediatr Adolesc Med (1996) 2.68
H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics (1983) 2.62
Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr (1988) 2.62
Origin of major histocompatibility complex polymorphism: the trans-species hypothesis. Hum Immunol (1987) 2.51
Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature (1978) 2.51
The polymer mat: arrested rebound of a compressed polymer layer. Eur Phys J E Soft Matter (2002) 2.43
Phylogeny of Darwin's finches as revealed by mtDNA sequences. Proc Natl Acad Sci U S A (1999) 2.42
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Polymorphism and balancing selection at major histocompatibility complex loci. Genetics (1992) 2.34
Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell (1996) 2.32
Directly measured second hand smoke exposure and asthma health outcomes. Thorax (2005) 2.32
Molecular characterisation of the Arabidopsis SBP-box genes. Gene (1999) 2.31
Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. J Exp Med (1978) 2.24
Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet (2000) 2.21
Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol (2001) 2.19
Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA (1994) 2.18
Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18
Evolution of the major histocompatibility complex. Crit Rev Immunol (1986) 2.16
Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck (1997) 2.16
Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol (2001) 2.14
Degradation of phenanthrene, fluorene and fluoranthene by pure bacterial cultures. Appl Microbiol Biotechnol (1990) 2.12
Wound expression of a potato proteinase inhibitor II gene in transgenic tobacco plants. EMBO J (1987) 2.12
H-2 mutations: their genetics and effect on immune functions. Adv Immunol (1978) 2.11
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry. Br J Dermatol (2011) 2.07
Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution. EMBO J (1988) 1.98
Serologic evidence for antigens controlled by the Ir region in mice. J Exp Med (1973) 1.94
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med (1990) 1.91
Graft-versus-host reactions across different regions of the H-2 complex of the mouse. J Exp Med (1973) 1.87
Patient choice modules for summaries of clinical effectiveness: a proposal. BMJ (2001) 1.83
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med (1990) 1.83
Fluidity of water confined to subnanometre films. Nature (2001) 1.80
Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain (2012) 1.77
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75
Production of anti-H-2 antibodies in thymectomized mice. Eur J Immunol (1974) 1.74
DNA archives and our nearest relative: the trichotomy problem revisited. Mol Phylogenet Evol (2000) 1.71
H-2 types of translocation stocks T(2;9)138Ca, T(9;13)-190Ca and an H-2 recombinant. Transplantation (1970) 1.71
Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology (2003) 1.70
Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse. J Exp Med (1972) 1.70
Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem (2000) 1.67
Genetics of the major histocompatibility complex: the final act. Annu Rev Immunol (1983) 1.65
Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry (1992) 1.65
Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia (2009) 1.64
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology (2007) 1.63
Validation of client decision-making instruments in the context of psychiatry. Can J Nurs Res (1996) 1.63
Polymorphism of the mouse H-2 loci. Immunol Rev (1981) 1.63
Determination of gestational cocaine exposure by hair analysis. JAMA (1989) 1.63
Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol (1990) 1.61
Graft versus host reaction in strains of mice identical for H-2K and H-2D antigens. Nat New Biol (1973) 1.61
The origin and age of haplochromine fishes in Lake Victoria, east Africa. Proc Biol Sci (2000) 1.59
Intensity of natural selection at the major histocompatibility complex loci. Proc Natl Acad Sci U S A (1994) 1.59
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
In irradiation chimeras, K or D regions of the chimeric host, not of the donor lymphocytes, determine immune responsiveness of antiviral cytotoxic T cells. J Exp Med (1978) 1.57
Omalizumab inhibits allergen challenge-induced nasal response. Eur Respir J (2004) 1.56
Private and public antigens of the mouse H-2 system. Nature (1971) 1.53
Cytological identification of the chromosome carrying the IXth linkage group (including H-2) in the house mouse. Proc Natl Acad Sci U S A (1971) 1.51
Characterization of Ia antigens in mouse serum. J Immunol (1976) 1.51
Structure of the murine Ia-associated invariant (Ii) chain as deduced from a cDNA clone. EMBO J (1984) 1.51
Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D₃ analogue in polymorphic light eruption. Br J Dermatol (2011) 1.50
Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains. J Exp Med (1981) 1.49
Hostility and myocardial ischemia in coronary artery disease patients: evaluation by gender and ischemic index. Psychosom Med (1993) 1.48
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant (2000) 1.48
Borrelia burgdorferi as an etiologic agent in chronic heart failure? Scand J Infect Dis Suppl (1991) 1.48
Immunologic protection afforded by sunscreens beyond designated sun protection factors? J Invest Dermatol (1998) 1.48
Photopheresis for renal allograft rejection. Lancet (1995) 1.47
On the origin of Darwin's finches. Mol Biol Evol (2001) 1.46
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
Genetic organization and evolution of the mouse H-2 region: a duplication model. Transplant Proc (1971) 1.44
Congenic mouse strains with different immunoglobulin allotypes. I. Breeding scheme, histocompatibility tests, and kinetics of gamma G2a-globulin production by transferred cells for C3H.SW and its congenic partner CWB/5. Transplantation (1967) 1.44
Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice. J Exp Med (1977) 1.44
Identification and characterization of amelogenin genes in monotremes, reptiles, and amphibians. Proc Natl Acad Sci U S A (1998) 1.43
A critical reappraisal of Waddell's technique for ultraviolet spectrophotometric protein estimation. Anal Biochem (1983) 1.43
The H-2 system: past and present. Transplant Proc (1973) 1.42
Helical body CT: evolution of scanning protocols. AJR Am J Roentgenol (1998) 1.42
Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett (2001) 1.42
Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope (1995) 1.42
Ia antigens as restriction molecules in Ir-gene controlled T-cell proliferation. Immunol Rev (1981) 1.42
Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy. J Cardiovasc Electrophysiol (1996) 1.42
Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance. Clin Endocrinol (Oxf) (2013) 1.41
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
Technology assessment. Old, new, and needs-based. Int J Technol Assess Health Care (1995) 1.41
Reprinted article "A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery". Eur J Vasc Endovasc Surg (2011) 1.40
Isolation of 37 single-copy DNA probes from human chromosome 6 and physical mapping of 11 probes by in situ hybridization. Genomics (1991) 1.40